Insight Molecular (IMDX) Stock Rises Sharply After Strategic Shift
Last Friday saw a 34.18% increase in Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) shares, which ended the day at $4.24. A major rebranding push preceded the strong upward surge, which caused the company’s stock to rise 57.04% in just one week. Investor confidence in the company’s new emphasis and expanded trajectory outside cancer is reflected […]